Table 1.
Summary of studies examining the relationships between gastric diseases and gut microbiota
Disease conditions | Country | Sample size | Abundance of H. pylori in diseases | Microbial diversity | Taxon differences | References |
---|---|---|---|---|---|---|
NAG, IM, GC | Mexico | 5 NAG, 5 IM, 5 GC | ↓ | α-Diversity: NAG > IM > GC | ↑Lactobacillus, Lachnospiraceae from NAG, IM, to GC; ↓Saccaribacteria (TM7), Porphyromonas, Neisseria in GC | Aviles-Jimenez et al. 2014 |
GC | Korea | 34 GC, 29 control | ↓ | No difference in α- and β-diversity | ↑Actinobacteria, Staphylococcus epidermidis in GC; ↑ nitrosating/nitrate‐reducing bacteria in GC (not statistically significant) | Jo et al. 2016 |
Gastritis, IM, GC | Hong Kong | 8 Healthy control, 9 gastritis, 9 IM, 9 GC | ↑ |
↑ Shannon index in GC vs. gastritis ↓ phylogenetic diversity in GC vs. IM |
↑Flavobacterium, Klebsiella, Serratia marcescens, Stenotrophomonas, Achromobacter, Pseudomonas, Delftia, Ralstonia, Rhizobium, Elizabethkingia meningoseptica, Methyloversatiis, Gp4, Cytophagaceae in GC | Li et al. 2017 |
GC, CG | China | 6 GC, 5 CG | ↓ | ↓Bacterial richness in GC, but not Shannon diversity index | ↑ Neisseria, Alloprevotella, Aggregatibacter, Streptococcus mitis and Porphyromonoas endodontalis in GC; ↓Sphingobium yanoikuyae in GC | Hu et al. 2012 |
Gastritis, GC | Portugal | Discovery cohort: 81 gastritis, 54 GC | ↓ | ↓α-Diversity in GC | ↑Citrobacter, Clostridium, Lactobacillus, Achromobacter, and Rhodococcus in GC patients | Ferreira et al. 2018 |
GC | China | 276 GC | ↓ | ↓α-Diversity in GC | ↓Prevotella copri and Bacteroides uniformis; ↑Prevotella melaninogenica, Streptococcus anginosus and Propionibacterium acnes | Liu et al. 2019 |
GC | Korea | 288 GC, 288 control | ↑ | ↓α-Diversity in GC | ↑Prevotella copri and Propionibacterium acnes in GC; ↑ Lactococcus lactis in controls | Gunathilake et al. 2019 |
GC, gastritis, atrophy, IM | Mongolia | 48 GC, 120 control (20 healthy, 20 gastritis, 40 atrophy, 40 IM) | ↓ | α-Diversity: normal > IM > GC > gastritis and atrophy | ↑Enterococcus, Lactobacillus, Carnobacterium, Glutamicibacter, Paeniglutamicibacter, Fusobacterium, and Parvimonas in GC | Gantuya et al. 2019 |
Gastric ulcer, duodenal ulcer | China | Gastric ulcer, duodenal ulcer | ↑ | ↓α-Diversity in DU | ↑Helicobacter, Prevotella, Neisseria and Streptococcus | Chen et al. 2018a, b |
Gastritis | Germany | Gastritis | ↑ | No significant difference | ↑Helicobacter, Streptococcus | Schulz et al. 2018 |
Gastritis,IM, GC | China | Gastritis,IM, GC | ↓ | No significant difference | ↑Burkholderia, Enterobacter, and Leclercia, Clostridium, Fusobacterium in non-GC; ↑Lactobacillus in GC, C. colicanis and F. nucleatum represent diagnostic markers for GC | Hsieh et al. 2018 |
Superficial gastritis, atrophic gastritis, IM, GC | China | 21 superficial gastritis, 23 atrophic gastritis, 17 IM, 20 GC | ↓ | ↓α-Diversity in GC and IM vs. SG | ↑oral flora, Peptostreptococcus stomatis, Streptococcus anginosus, Parvimonas micra, Slackia exigua and Dialister pneumosintes in GC; ↓Vogesella, Comamonadaceae and Acinetobacter in GC | Coker et al. 2018 |
Dyspepsia | Spain | Dyspepsia | ↓ | No significant difference | ↑Propionibacterium, Lactobacillus, Streptococcus and Staphylococcus | Delgado et al. 2013 |
GC, dyspepsia | Sweden | 10 GC, 5 dyspepsia | ↓ | No significant difference | N/A | Dicksved et al. 2009 |
GC, dyspepsia | Singapore and Malaysia | 12 GC, 20 dyspepsia | ↓ | ↑α-Diversity in GC | ↑Lactococcus, Veilonella, and Fusobacteriaceae (Fusobacterium and Leptotrichia) in GC | Castaño‐Rodríguez et al. 2017 |
HP infection | India | HP infection suspected | ↑ | ↑α-Diversity | ↑Helicobacter,Lactobacillus, Halomonas and Prevotella | Das et al. 2017 |
HP infection | China | HP infection suspected | ↑ | ↓α-Diversity | ↓Stenotrophomonas maltophilia, Stenotrophomonas unclassified, Variovorax unclassified, Chryseobacterium unclassified, Comamonas unclassified, and Pseudomonas stutzeri | Wang et al. 2022 |
GC gastric cancer, CG chronic gastritis, NAG non-atrophic gastritis, IM intestinal metaplasia, N/A not available. The “↑” arrow indicates the increase in H.pylori abundance/alpha diversity/ microbial diversity of the diseases and the “↓” indicates the decrease in H.pylori abundance/alpha diversity/ microbial diversity of the diseases